Trial intelligence / Profile preview

Intrathecal dexmedetomidine dose comparison in elective caesarean section spinal anesthesia

IRCT20260225068946N1Phase 4Completed

Sponsor
Superior University
Start
Aug 2026
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of dexmedetomidine and bupivacaine in procedural pain (4 arms), sponsored by Superior University. Primary endpoints: Onset of sensory block, Duration of sensory block and 3 more. Started Aug 2026; status: completed.

02

Drugs

dexmedetomidinebupivacaine
03

Conditions

procedural pain

Beyond the preview

Go deeper on IRCT20260225068946N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20260225068946N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call